Prada SpA (1913)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 23 Oct 2026
Key indicators
| Last close | HKD 38.80 |
|---|---|
| 52-week range | 34.52 – 52.00 |
| Return, 1 month / 3 months | +1.7% / −3.9% |
| Return, 1 year / 3 years | −12.7% / −7.3% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -30.9% |
| Average daily value traded | 70.95M HKD |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Prada is an Italian luxury fashion house based in Milan. It designs, makes and sells high-end handbags, leather goods, footwear and ready-to-wear clothing for men and women, along with eyewear and fragrances under licence. Its collections appear under the Prada and Miu Miu labels and reach customers through the company's own boutiques and selected department stores in cities around the world.
On this site Prada SpA appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 1913, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Prada SpA (1913) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 38.80 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 311 of 2,613 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.7% and over the last three months it fell 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -22.8% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.9% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | -14.2% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.9% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 70.95M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | +1.7% |
| 3 months | −3.9% |
| 6 months | +7.1% |
| 1 year | −12.7% |
| 3 years | −7.3% |
| 5 years | −10.0% |
Signals
| 50-day / 200-day average | 39.18 / 38.90 |
|---|---|
| Golden / death cross (60 days) | Golden, 49 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | HKD 1.5026 |
| 6 May 2025 | HKD 1.4318 |
| 29 Apr 2024 | HKD 1.1339 |
| 3 May 2023 | HKD 0.9544 |
| 4 May 2022 | HKD 0.5796 |
| 2 Jun 2021 | HKD 0.3315 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.